Total Payments
$2,174
2024 Payments
$192.17
Companies
39
Transactions
139
Medicare Patients
22,392
Medicare Billing
$6.0M
Payment Breakdown by Category
Food & Beverage$2,151 (99.0%)
Education$22.72 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,151 | 137 | 99.0% |
| Education | $22.72 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $436.29 | 31 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $216.61 | 12 | $0 (2023) |
| Celgene Corporation | $201.57 | 12 | $0 (2024) |
| PFIZER INC. | $122.49 | 12 | $0 (2023) |
| ABBVIE INC. | $121.84 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $119.44 | 8 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $96.82 | 8 | $0 (2020) |
| ARRAY BIOPHARMA INC | $82.76 | 4 | $0 (2023) |
| Daiichi Sankyo Inc. | $55.51 | 2 | $0 (2023) |
| EMD Serono, Inc. | $55.12 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $192.17 | 9 | ABBVIE INC. ($80.19) |
| 2023 | $443.10 | 27 | PFIZER INC. ($74.84) |
| 2022 | $243.98 | 14 | E.R. Squibb & Sons, L.L.C. ($46.39) |
| 2021 | $254.14 | 14 | Pharmacyclics LLC, An AbbVie Company ($89.10) |
| 2020 | $97.15 | 5 | Daiichi Sankyo Inc. ($40.81) |
| 2019 | $99.32 | 7 | E.R. Squibb & Sons, L.L.C. ($26.96) |
| 2018 | $517.83 | 37 | E.R. Squibb & Sons, L.L.C. ($127.57) |
| 2017 | $326.37 | 26 | E.R. Squibb & Sons, L.L.C. ($103.29) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Oncology | ||||||
| 05/28/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.41 | General |
| Category: Hematology | ||||||
| 05/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: Hematology | ||||||
| 04/16/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Oncology | ||||||
| 03/18/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Hematology | ||||||
| 12/09/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: ONCOLOGY | ||||||
| 11/28/2023 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Genetically Defined Disease | ||||||
| 11/21/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2023 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2023 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $24.55 | General |
| Category: Oncology | ||||||
| 10/17/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.83 | General |
| Category: Prostate cancer | ||||||
| 09/06/2023 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $12.77 | General |
| Category: Hematology | ||||||
| 09/05/2023 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $2.85 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2023 | AVEO Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $39.71 | General |
| Category: Oncology | ||||||
| 08/03/2023 | CTI BioPharma Corp. | Vonjo (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Hematology | ||||||
| 07/14/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 71 | 5,431 | 132,552 | $5.5M | $1.4M |
| 2022 | 72 | 5,469 | 117,836 | $5.7M | $1.4M |
| 2021 | 75 | 5,951 | 136,901 | $5.6M | $1.6M |
| 2020 | 74 | 5,541 | 146,589 | $6.1M | $1.6M |
Total Patients
22,392
Total Services
533,878
Medicare Billing
$6.0M
Procedure Codes
300
All Medicare Procedures & Services
300 procedure records from CMS Medicare Utilization — Page 3 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,025 | $709.50 | 69.2% |
| J9263 | Injection, oxaliplatin, 0.5 mg | Office | 2023 | 19 | 11,500 | $23,000 | $659.14 | 2.9% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 21 | 41 | $2,263 | $610.08 | 27.0% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2023 | 19 | 5,712 | $6,835 | $573.31 | 8.4% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 12 | 14 | $4,342 | $547.10 | 12.6% |
| J9045 | Injection, carboplatin, 50 mg | Office | 2023 | 19 | 267 | $4,506 | $540.34 | 12.0% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 17 | 22 | $1,944 | $534.60 | 27.5% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 17 | 35 | $2,002 | $508.18 | 25.4% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 15 | 29 | $2,092 | $403.41 | 19.3% |
| 96377 | Application of on-body injector for under skin injection | Office | 2023 | 17 | 24 | $1,286 | $333.12 | 25.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 105 | 2,724 | $2,724 | $264.61 | 9.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 58 | $580.00 | $197.78 | 34.1% |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | Office | 2023 | 22 | 420 | $1,680 | $123.77 | 7.4% |
| 84100 | Phosphate level | Office | 2023 | 15 | 25 | $350.00 | $116.25 | 33.2% |
| 85044 | Red blood count, manual test | Office | 2023 | 22 | 22 | $270.00 | $92.84 | 34.4% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 12 | 14 | $255.00 | $88.76 | 34.8% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 57 | 108 | $345.00 | $84.08 | 24.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 11 | 16 | $584.00 | $66.34 | 11.4% |
| 85045 | Red blood count, automated test | Office | 2023 | 15 | 16 | $176.00 | $62.56 | 35.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 22 | 45 | $270.00 | $53.28 | 19.7% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 12 | 14 | $154.00 | $52.08 | 33.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 12 | 12 | $144.00 | $47.28 | 32.8% |
| J3490 | Unclassified drugs | Office | 2023 | 33 | 67 | $201.00 | $42.48 | 21.1% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2023 | 14 | 19 | $152.00 | $38.43 | 25.3% |
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2022 | 22 | 9,600 | $1.6M | $405,078 | 24.9% |
About Dr. Stacey Knox, MD
Dr. Stacey Knox, MD is a Hematology & Oncology healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750353447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Knox, MD has received a total of $2,174 in payments from pharmaceutical and medical device companies, with $192.17 received in 2024. These payments were reported across 139 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,151).
As a Medicare-enrolled provider, Knox has provided services to 22,392 Medicare beneficiaries, totaling 533,878 services with total Medicare billing of $6.0M. Data is available for 4 years (2020–2023), covering 300 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Lincoln, NE
- Active Since 02/06/2006
- Last Updated 03/16/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1750353447
Products in Payments
- OPDIVO (Biological) $257.99
- IMBRUVICA (Drug) $184.77
- KEYTRUDA (Biological) $96.82
- EMPLICITI (Biological) $84.09
- EPKINLY (Drug) $70.99
- REBLOZYL (Biological) $69.87
- IBRANCE (Drug) $62.30
- XALKORI (Drug) $57.76
- Enhertu (Drug) $55.51
- Revlimid (Drug) $53.59
- Vonjo (Drug) $48.08
- AFINITOR (Drug) $46.14
- VENCLEXTA (Drug) $41.65
- Imbruvica (Drug) $41.04
- FOTIVDA (Drug) $39.71
- ONUREG (Drug) $36.94
- Kyprolis (Biological) $31.43
- Stivarga (Drug) $31.13
- Somatuline Depot (Drug) $29.72
- JEMPERLI (Biological) $28.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Lincoln
Mr. Steven Dunder, Md, MD
Hematology & Oncology — Payments: $26,199
Hematology & Oncology $26,199
Nathan Green, Do, DO
Hematology & Oncology — Payments: $10,159
Hematology & Oncology $10,159
Wallace Peterson, Md, MD
Hematology & Oncology — Payments: $6,017
Hematology & Oncology $6,017
Melissa Cetak, Aprn, APRN
Hematology & Oncology — Payments: $5,017
Hematology & Oncology $5,017
Dr. Joni Tilford, Md, MD
Hematology & Oncology — Payments: $4,721
Hematology & Oncology $4,721
Dr. Matthew Shupe, D.o, D.O
Hematology & Oncology — Payments: $4,207
Hematology & Oncology $4,207